Investigational Site Number : 1560039
Hangzhou
0 studies enrolling now · 1 studies all time
What they study most
Chronic Obstructive Pulmonary Disease
Studies at this site
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
— Completed